CPA5
Carboxypeptidase A5
Also known as: CBPA5_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WXQ8
- Gene
- CPA5
- Ensembl
- ENSG00000158525
- Chromosome
- 7
- Canonical length
- 436 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Nucleoplasm
- Secretome location
- Secreted in male reproductive system
OverviewNCBI Gene
Carboxypeptidases have functions ranging from digestion of food to selective biosynthesis of neuroendocrine peptides. Members of the A/B subfamily of carboxypeptidases, such as CPA5, contain an approximately 90-amino acid pro region that assists in the folding of the active carboxypeptidase domain. Cleavage of the pro region activates the enzyme (Wei et al., 2002 [PubMed 11836249]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
436 residues, UniProt reviewed canonical sequence.
>Q8WXQ8|CPA5
1 MQGTPGGGTR PGPSPVDRRT LLVFSFILAA ALGQMNFTGD QVLRVLAKDE KQLSLLGDLE
61 GLKPQKVDFW RGPARPSLPV DMRVPFSELK DIKAYLESHG LAYSIMIKDI QVLLDEERQA
121 MAKSRRLERS TNSFSYSSYH TLEEIYSWID NFVMEHSDIV SKIQIGNSFE NQSILVLKFS
181 TGGSRHPAIW IDTGIHSREW ITHATGIWTA NKIVSDYGKD RVLTDILNAM DIFIELVTNP
241 DGFAFTHSMN RLWRKNKSIR PGIFCIGVDL NRNWKSGFGG NGSNSNPCSE TYHGPSPQSE
301 PEVAAIVNFI TAHGNFKALI SIHSYSQMLM YPYGRLLEPV SNQRELYDLA KDAVEALYKV
361 HGIEYIFGSI STTLYVASGI TVDWAYDSGI KYAFSFELRD TGQYGFLLPA TQIIPTAQET
421 WMALRTIMEH TLNHPYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CPA5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 30 nTPM
Expression across tissuesHPA
Tissue
- testis: 30 nTPM
- thymus: 2.1 nTPM
- lymph node: 1.8 nTPM
- spleen: 1.7 nTPM
- pituitary gland: 1.2 nTPM
- skin: 0.9 nTPM
Single-cell type
- late spermatids: 258 nCPM
- early spermatids: 64 nCPM
- late primary spermatocytes: 55 nCPM
- myosatellite cells: 8 nCPM
- syncytiotrophoblasts: 5.7 nCPM
- cytotrophoblasts: 4.1 nCPM
Immune cell
- T-reg: 57 nTPM
- naive CD8 T-cell: 43 nTPM
- memory CD4 T-cell: 17 nTPM
- memory CD8 T-cell: 8.6 nTPM
- total PBMC: 5.8 nTPM
- naive CD4 T-cell: 4.2 nTPM
Brain region
- hypothalamus: 0.8 nTPM
- cerebral cortex: 0.6 nTPM
- pons: 0.6 nTPM
- white matter: 0.6 nTPM
- midbrain: 0.5 nTPM
- medulla oblongata: 0.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.75
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.59
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CPA5 as an antibody target. Whether an autoantibody or antibody against CPA5 could matter depends on whether native CPA5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CPA5 is annotated as secreted, so native CPA5 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label CPA5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...